EXOSENS Shares Plunge 19% in a Week, Hitting a One-Month Low
EXOSENS shares continue their decline this Friday, March 27, dropping 4.25% to €56.3 mid-session, after a previous close at €58.8. The stock simultaneously breaches its one-month low and records a weekly performance of -19.34%, one of the most significant since its introduction. This dual technical signal occurs in a context of high market volatility, with the VIX trading around 25.33.
EXOSENS has erased a large portion of the gains accumulated over three months in just a few sessions, with its one-month performance at -9.78%, while the one-year outlook remains strongly positive at +64.6%. The weekly drop of 19.34% far exceeds usual volatility thresholds and indicates unusual selling pressure on the stock. Technically, the price is now below its 50-day moving average, set at €60.01, marking a significant bearish crossover. The RSI is at 40, in moderately low territory, without indicating an extreme oversold zone. The nearest support is at €55.60, less than 1.3% below the current price. Breaking below this level could lead to untested levels for several weeks.
Challenging Day for Tech and Industrial Stocks
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
March 27 proves to be a challenging day for the entire technology and industrial sector. ASML Holding is down by 2.80% and Schneider Electric drops 2.46%, illustrating widespread pressure on growth stocks in a tense market environment. Regarding the calendar, the next key dates that could shed light on the operational dynamics of the group are the publication of the first quarter 2026 results, expected on April 27, followed by the annual general meeting on May 22. These events could serve as reference points for operators monitoring the evolution of the case since the strong acceleration recorded over the past twelve months.
Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
Dépendance aux budgets de Défense et aux évolutions géopolitiques
Risque d'intégration des acquisitions récentes
Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
